These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 8830160

  • 1. Chemotherapy-induced non-Hodgkin's lymphoma in a patient with Hodgkin's disease--a case report.
    Burney IA, Malik IA.
    J Pak Med Assoc; 1996 Jan; 46(1):14-5. PubMed ID: 8830160
    [No Abstract] [Full Text] [Related]

  • 2. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
    Andrieu JM, Colonna P.
    J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234
    [No Abstract] [Full Text] [Related]

  • 3. Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.
    Scholz M, Engert A, Franklin J, Josting A, Diehl V, Hasenclever D, Loeffler M.
    Ann Oncol; 2011 Mar; 22(3):681-688. PubMed ID: 20720088
    [Abstract] [Full Text] [Related]

  • 4. [Thymus hyperplasia after chemotherapy in a case of Hodgkin's disease].
    Andreopoulos D, Klose KC, Glöckner WM.
    Rofo; 1991 Oct; 155(4):375-6. PubMed ID: 1718486
    [No Abstract] [Full Text] [Related]

  • 5. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
    Paoli D, Rizzo F, Fiore G, Pallotti F, Pulsoni A, Annechini G, Lombardo F, Lenzi A, Gandini L.
    Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
    [Abstract] [Full Text] [Related]

  • 6. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB, Petroni GR, Johnson JL, Glick JH, Fisher RI, Connors JM, Canellos GP, Peterson BA.
    J Clin Oncol; 2003 Feb 15; 21(4):607-14. PubMed ID: 12586796
    [Abstract] [Full Text] [Related]

  • 7. Long-term follow-up of survival in Hodgkin's lymphoma.
    Canellos GP, Niedzwiecki D, Johnson JL.
    N Engl J Med; 2009 Dec 10; 361(24):2390-1. PubMed ID: 20007568
    [No Abstract] [Full Text] [Related]

  • 8. ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
    Viviani S, Zinzani PL, Rambaldi A, Brusamolino E, Levis A, Bonfante V, Vitolo U, Pulsoni A, Liberati AM, Specchia G, Valagussa P, Rossi A, Zaja F, Pogliani EM, Pregno P, Gotti M, Gallamini A, Rota Scalabrini D, Bonadonna G, Gianni AM, Michelangelo Foundation, Gruppo Italiano di Terapie Innovative nei Linfomi, Intergruppo Italiano Linfomi.
    N Engl J Med; 2011 Jul 21; 365(3):203-12. PubMed ID: 21774708
    [Abstract] [Full Text] [Related]

  • 9. Early intensification treatment approach in advanced-stage Hodgkin lymphoma.
    Borchmann P.
    Hematol Oncol Clin North Am; 2014 Feb 21; 28(1):65-74. PubMed ID: 24287068
    [Abstract] [Full Text] [Related]

  • 10. Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
    Vose JM, Anderson JR, Bierman PJ, Bast M, Weisenburger D, Chan WC, Bishop MR, Armitage JO.
    Semin Hematol; 1994 Apr 21; 31(2 Suppl 3):4-8. PubMed ID: 7521065
    [No Abstract] [Full Text] [Related]

  • 11. Sarcoidosis following escalated BEACOPP chemotherapy for stage IV Hodgkin lymphoma.
    Cho KK, Lyes SM, Shetty A.
    Intern Med J; 2019 Apr 21; 49(4):547-548. PubMed ID: 30957369
    [No Abstract] [Full Text] [Related]

  • 12. [Non-Hodgkin's lymphoma secondary to Hodgkin's disease treated with chemo- and radiotherapy. Report of a case].
    Gamboa Domínguez A, Pita Ramírez L, Hurtado Monroy R, Angeles-Angeles A.
    Rev Invest Clin; 1992 Apr 21; 44(3):393-8. PubMed ID: 1283228
    [Abstract] [Full Text] [Related]

  • 13. Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study.
    Clin Adv Hematol Oncol; 2016 Feb 21; 14(2 Suppl 1):9-10. PubMed ID: 27007004
    [No Abstract] [Full Text] [Related]

  • 14. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y, Shi YK, He XH, Feng FY, Zhou LQ, Gu DZ.
    Zhonghua Zhong Liu Za Zhi; 2008 Aug 21; 30(8):630-4. PubMed ID: 19102946
    [Abstract] [Full Text] [Related]

  • 15. [Diffuse thymus hyperplasia following chemotherapy for nodular sclerosing Hodgkin lymphoma].
    Hermann R, Greminger P, Dommann-Scherrer C, Krestin GP, Stahel R.
    Schweiz Med Wochenschr; 1994 Sep 24; 124(38):1666-71. PubMed ID: 7524146
    [Abstract] [Full Text] [Related]

  • 16. [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
    Zhen ZJ, Sun XF, Xia Y, Wang ZH, Ling JY.
    Ai Zheng; 2006 Apr 24; 25(4):471-5. PubMed ID: 16613683
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of advanced Hodgkin lymphoma].
    Kreissl S, Borchmann P.
    Dtsch Med Wochenschr; 2013 Jun 24; 138(23):1212-4. PubMed ID: 23720173
    [No Abstract] [Full Text] [Related]

  • 18. Essential thrombocythemia after treatment of non-Hodgkin's lymphoma.
    Maciel JF, de Lourdes Chauffaille M, Inaoka RJ, Colleoni GW, Yamamoto M.
    Leuk Res; 2007 Nov 24; 31(11):1593-5. PubMed ID: 17324461
    [No Abstract] [Full Text] [Related]

  • 19. MOPP, ABVD, or both to treat Hodgkin's disease.
    Aisenberg AC.
    N Engl J Med; 1993 Apr 08; 328(14):1045; author reply 1045-6. PubMed ID: 7680765
    [No Abstract] [Full Text] [Related]

  • 20. The effects of four drug regimens on sister chromatid exchange frequency in patients with lymphomas.
    Brown T, Dawson AA, Bennett B, Moore NR.
    Cancer Genet Cytogenet; 1988 Nov 08; 36(1):89-102. PubMed ID: 3203299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.